IRM is pleased to showcase Neuren Pharmaceuticals Limited.

Neuren Pharmaceuticals (ASX: NEU) is a biopharmaceutical company focusing on the development of new therapies for brain injury, neurodevelopmental and neurodegenerative disorders.